Better Science，Better Health
Better Science，Better Health
Industry Fund
Leading Early-Stage Value Investor in China's Healthcare Sector
BAHEAL ZHONGXIN CAPITAL currently has RMB 4 billion under management. Leveraging Baheal Pharma Group’s technology innovation and resource integration platform, BAHEAL ZHONGXIN CAPITAL focuses on investing in and incubating healthcare products and services with technological differentiation that can truly optimize clinical practice.Visit the official website
Early Stage
New and Innovative
Long-Term Commitment
Incubation System
Innovation Incubation Ecosystem
Industrial Space
Clinical Medical Services
Digitalization Capability
Market Research
Capital Funding
Patent Management
Human Resources
R&D Project Management
...
Regulatory Registration Services
Cutting-Edge Medical Collaboration
